Dermatomyositis: Clinical features and pathogenesis.
DeWane ME, Waldman R, Lu J.
J Am Acad Dermatol. 2020 Feb;82(2):267-281. doi: 10.1016/j.jaad.2019.06.1309. Epub 2019 Jul 4.
Characteristics of dermatomyositis patients with and without associated malignancy.
Lauinger J, Ghoreschi K, Volc S.
J Dtsch Dermatol Ges. 2021 Nov;19(11):1601-1611. doi: 10.1111/ddg.14566. Epub 2021 Nov 5.
Dermatomyositis: Diagnosis and treatment.
Waldman R, DeWane ME, Lu J.
J Am Acad Dermatol. 2020 Feb;82(2):283-296. doi: 10.1016/j.jaad.2019.05.105. Epub 2019 Jul 4.
Hematological malignancy associated with polymyositis and dermatomyositis.
Marie I, Guillevin L, Menard JF, Hatron PY, Cherin P, Amoura Z, Cacoub P, Bachelez H, Buzyn A, Le Roux G, Ziza JM, Brice P, Munck JN, Sarrot-Reynauld F, Piette JC, Larroche C.
Autoimmun Rev. 2012 Jul;11(9):615-20. doi: 10.1016/j.autrev.2011.10.024. Epub 2011 Oct 30.
Paraneoplastic Wong-Type Dermatomyositis Associated with Gynecological Malignancy.
Russo R, Gasparini G, Cozzani E, Gravina B, Parodi A.
Medicina (Kaunas). 2022 Mar 27;58(4):484. doi: 10.3390/medicina58040484.
Paraneoplastic dermatomyositis associated with testicular malignancy.
Chiu SH, Fang WC, Lan CE, Su YC.
Kaohsiung J Med Sci. 2020 Dec;36(12):1038-1039. doi: 10.1002/kjm2.12288. Epub 2020 Aug 7.
Trastuzumab-Associated Dermatomyositis.
Waheed S, Zubair HM, Waheed F, Iqbal SM.
Am J Ther. 2019 Sep/Oct;26(5):e647-e649. doi: 10.1097/MJT.0000000000000849.
Amyopathic dermatomyositis associated with malignancy.
Finger DR, Dunn CL, Gilliland WR, James WD.
Int J Dermatol. 1996 Sep;35(9):663-4. doi: 10.1111/j.1365-4362.1996.tb03698.x.
Cancer-associated Dermatomyositis with Histiocytic Sarcoma.
Tsutsumi M, Shimasaki Y, Koga T, Kaieda S.
Intern Med. 2022 Jan 15;61(2):277-278. doi: 10.2169/internalmedicine.7995-21. Epub 2021 Jul 10.
Dermatomyositis-Part 2: Diagnosis, Association With Malignancy, and Treatment.
Ramos-E-Silva M, Lima Pinto AP, Pirmez R, Cuzzi T, Carneiro S.
Skinmed. 2016 Oct 1;14(5):354-358. eCollection 2016.
